Grant: Alliance Grants
Dalhousie University
$25,000.00
Understanding the roles of gibberellic acid hormone and elsinochrome phytotoxins in pathogenesis of cassava superelongation disease
EF 2023-24
Résumé
The root crop Manihot esculenta Crantz (cassava; also commonly called manioc or yuca) is an important staple for over a billion people in tropical and subtropical regions of the world. Cassava is extensively cultivated, and production has increased considerably over the last 20 years. Although used mainly for consumption, cassava is also utilized for industrial production and animal feed. Cassava is considered an excellent food security crop as the tubers can remain in the ground until needed, and it is highly adaptable to changes in climate, growing well in poor soil and tolerant of drought conditions. However, cassava grown in the Caribbean and Latin America is under threat from Superelongation Disease (SED), caused by the fungal pathogen Elsinöe brasiliensis. Disease symptoms include spots on leaves that coalesce leading to defoliation, and dramatic elongation that weakens the stem causing the plant to fall. The impact on yield is significant, with up to 80% crop loss, reduced root size and poor-quality tuber. Very little is known about E. brasiliensis and plant immune responses to defend against the pathogen, which limits our ability to implement strategies to secure the crop. This collaboration will examine the potential roles of fungal- and plant-produced hormone gibberellic acid in modulating susceptibility to the disease and resistance to the pathogen. We will also examine the role of phytotoxins produced by E. brasiliensis in promoting SED. We aim to develop a novel fungal-plant pathosystem, which will enable molecular genetic experiments required for in-depth analyses of host defense mechanisms. This study will provide much needed insight into the role of fungal-derived GA in pathogenicity, and the function of the phytohormone in plant immune responses to pathogenic fungi. Knowledge gained will be key to the development of protection strategies needed to mitigate the devastating impact of SED on cassava production, including development of simple and early detection methods to eliminate infected planting material (stem cuttings), identification of small molecules that act as anti-virulence factors to limit infection, and targeted genome editing to reduce susceptibility.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
586547-2023
Name nom
Stone, Sophia SL
Department département
Biology
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
4906
Research subject group en
Plant and treebiology
Research subject group fr
Plant pathology
Research subject en
Biologie végétale et des arbres
Research subject fr
Phytopathologie
Application title
Understanding the roles of gibberellic acid hormone and elsinochrome phytotoxins in pathogenesis of cassava superelongation disease
Keyword
Arabidopsis; Cassava; Elsinochrome toxins; Gibberellin acid; Pathogenic fungi; Plant pathology; Superelongation disease
Application summary
The root crop Manihot esculenta Crantz (cassava; also commonly called manioc or yuca) is an important staple for over a billion people in tropical and subtropical regions of the world. Cassava is extensively cultivated, and production has increased considerably over the last 20 years. Although used mainly for consumption, cassava is also utilized for industrial production and animal feed. Cassava is considered an excellent food security crop as the tubers can remain in the ground until needed, and it is highly adaptable to changes in climate, growing well in poor soil and tolerant of drought conditions. However, cassava grown in the Caribbean and Latin America is under threat from Superelongation Disease (SED), caused by the fungal pathogen Elsinöe brasiliensis. Disease symptoms include spots on leaves that coalesce leading to defoliation, and dramatic elongation that weakens the stem causing the plant to fall. The impact on yield is significant, with up to 80% crop loss, reduced root size and poor-quality tuber. Very little is known about E. brasiliensis and plant immune responses to defend against the pathogen, which limits our ability to implement strategies to secure the crop. This collaboration will examine the potential roles of fungal- and plant-produced hormone gibberellic acid in modulating susceptibility to the disease and resistance to the pathogen. We will also examine the role of phytotoxins produced by E. brasiliensis in promoting SED. We aim to develop a novel fungal-plant pathosystem, which will enable molecular genetic experiments required for in-depth analyses of host defense mechanisms. This study will provide much needed insight into the role of fungal-derived GA in pathogenicity, and the function of the phytohormone in plant immune responses to pathogenic fungi. Knowledge gained will be key to the development of protection strategies needed to mitigate the devastating impact of SED on cassava production, including development of simple and early detection methods to eliminate infected planting material (stem cuttings), identification of small molecules that act as anti-virulence factors to limit infection, and targeted genome editing to reduce susceptibility.